Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-24 @ 10:01 PM
NCT ID:
NCT00055432
Eligibility Criteria:
Inclusion Criteria:
* Patients must have disease that can be measured.
* Patients must meet criteria for either platinum-resistant or platinum-sensitive ovarian or peritoneal cancer.
* Patients may only have had one prior platinum-based chemotherapy regimen.
* Patients must be willing and able to stop all aspirin and NSAID medications immediately before and for a time after each treatment cycle (approx. 5-8 days)
* Patients must have normal kidney function.
Exclusion Criteria:
* Patients may not have a Low Malignant Potential or Borderline Ovarian Tumor.
* Patients may not have received pelvic or abdominal radiotherapy.
* Patients must not have evidence of or received treatment for another cancer within the last 5 years.
* Patients must not have been diagnosed with a heart attack in the last 6 months.
* Patients who are unwilling or unable to take folic acid tablets, vitamin B12 injections or dexamethasone tablets.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00055432
Study Brief:
Protocol Section:
NCT00055432